Cell4Cure AB
Pioneering antigen-specific immune tolerance therapies using engineered dendritic cells.
Yleiskatsaus
- Tuntematon
- Työntekijät
- 37t SEK
- Liikevaihto
- 2023
- Perustettu
Avainpäättäjät
Christina Herder
Founder & CEO
Fredrik Gustavsson
Founder & Business Development
Agneta Edberg
Founder & Chairman
Hamid Bakhshi
Founder
+7 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Cell4Cure AB is a Swedish biotech company established in 2023, pioneering advanced immune tolerance therapies. Its proprietary platform leverages ex vivo-generated dendritic cells (DCs) engineered specifically to induce antigen-specific immune tolerance. This technology is designed to mitigate criti...